Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2003

View Archived Issues

Strong antidiabetic effects reported for exenatide in patients with type 2 diabetes

ICA-17043 ameliorates RBC dehydration in murine model of anemia

Blockade of IL-6 reported to reduce VEGF production in rheumatoid arthritis

At-home study of TA-1790 opens enrollment

New European label for Pegasys reflects new genotype data

Takeda scientists describe novel inhibitors of IL-8 production

JT researchers present new edg5 antagonists with antifibrotic activity

New ErbB kinase inhibitors under study at GSK

Kyorin and Nisshin Pharma patent new mu opioid receptor antagonists

Cuban researchers identify CKII inhibitors with potential in cancer therapy

CDK2/CDK4 inhibitors prepared and tested by GSK researchers

Orexin-1 antagonists and their use in obesity, sleep disorders, etc.

Glivec approved in Japan for KIT (CD117)-positive GIST

Zemaira receives FDA approval

Aventis Behring develops improved diagnostic test for human prion detection

AACR news: agonist antibodies to TRAIL-R2 show promise for the treatment of cancer

Small-molecule Bcl-xL/Bcl-2 antagonist with potential for combination therapy

CanBas identifies peptide with the ability to abrogate the G2 cell cycle checkpoint

Small-molecule inhibitor of IGF-IR kinase activity characterized at cancer meeting

New-generation NNRTI with potential for use in NNRTI-experienced HIV patients

Antithrombotic effects described for subcutaneous ART-123 in surgical patients

Ximelagatran in the prevention of DVT

Rosiglitazone beneficial in the treatment of HIV-related lipodystrophy

Ampligen delays HIV rebound during structured HAART interruption

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...